Glaukos Corp
GKOS
ISIN null / Valor 28262610
Glaukos Corp
UMushroom community rating:
About company
Glaukos Corp, founded in 1998, is an ophthalmic medical technology and pharmaceutical company that specializes in developing and commercializing innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company is known for pioneering Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to traditional glaucoma treatments, with a portfolio of technologically distinct platforms aimed at advancing the standard of care in ophthalmology. Glaukos completed an initial public offering in 2015 and is listed on the New York Stock Exchange under the ticker symbol "GKOS". With global headquarters in Aliso Viejo, California, and additional locations in several countries, Glaukos is dedicated to providing better treatment options for patients worldwide.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
6256 M
Market cap (USD)
1,563,945
Daily traded volume (Shares)
151.66 / 148.56
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
